Addex Therapeutics Ltd Income Tax Expense Continuing Operations
Addex Therapeutics Ltd (ADXN) reported Income Tax Expense Continuing Operations of CHF 0 for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-15.
Financial Statements › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2025-05-15
- Addex Therapeutics Ltd income tax expense continuing operations for the quarter ending 2023-06-30 was 0.00 CHF.
- Addex Therapeutics Ltd income tax expense continuing operations for the quarter ending 2022-06-30 was 0.00 CHF.
| Period end | Income Tax Expense Continuing Operations 3 month | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 12 month |
|---|---|---|---|
| 2024-12-31 | 0.00 CHF 20-F · filed 2025-05-15 | ||
| 2023-12-31 | 0.00 CHF 20-F · filed 2025-05-15 | ||
| 2023-06-30 | 0.00 CHF 6-K/A · filed 2023-12-21 | 0.00 CHF 6-K/A · filed 2023-12-21 | |
| 2022-12-31 | 0.00 CHF 20-F · filed 2025-05-15 | ||
| 2022-06-30 | 0.00 CHF 6-K/A · filed 2023-12-21 | 0.00 CHF 6-K/A · filed 2023-12-21 | |
| 2021-12-31 | 0.00 CHF 20-F · filed 2024-04-18 | ||
| 2020-12-31 | 0.00 CHF 20-F · filed 2023-03-30 | ||
| 2019-12-31 | 0.00 CHF 20-F · filed 2022-03-10 | ||
| 2018-12-31 | 0.00 CHF 20-F · filed 2021-03-11 |